Outlook Therapeutics (OTLK) Revenue & Revenue Breakdown
Outlook Therapeutics Revenue Highlights
00
Outlook Therapeutics Revenue by Period
Outlook Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2019-09-30 | $8.15M | 163.84% |
| 2018-09-30 | $3.09M | -18.99% |
| 2017-09-30 | $3.81M | 27.92% |
| 2016-09-30 | $2.98M | -42.91% |
| 2015-09-30 | $5.22M | -42.33% |
| 2014-09-30 | $9.05M | - |
Outlook Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Outlook Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | -100.00% |
| 2024-09-30 | $170.12K | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2019-09-30 | $5.85M | 902.66% |
| 2019-06-30 | $583.85K | -8.94% |
| 2019-03-31 | $641.14K | -39.97% |
| 2018-12-31 | $1.07M | 38.36% |
| 2018-09-30 | $771.89K | - |
| 2018-06-30 | $771.89K | - |
| 2018-03-31 | $771.89K | - |
| 2017-12-31 | $771.89K | -73.40% |
| 2017-09-30 | $2.90M | 857.35% |
| 2017-06-30 | $303.14K | -0.00% |
| 2017-03-31 | $303.14K | 0.00% |
| 2016-12-31 | $303.14K | -38.75% |
| 2016-09-30 | $494.89K | - |
| 2016-06-30 | $494.89K | -50.26% |
| 2016-03-31 | $994.89K | - |
| 2015-12-31 | $994.89K | 101.03% |
| 2015-09-30 | $494.89K | -61.78% |
| 2015-06-30 | $1.29M | 161.65% |
| 2015-03-31 | $494.89K | -83.14% |
| 2014-12-31 | $2.93M | - |
Outlook Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.